Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jan;89(1):122.
doi: 10.1136/bjo.2004.050575.

Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema

J B Jonas, I Kreissig, R F Degenring, B A Kamppeter

Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema

J B Jonas et al. Br J Ophthalmol. 2005 Jan.
No abstract available

PubMed Disclaimer

References

    1. Martidis A , Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–7. - PubMed
    1. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681–6. - PubMed
    1. Jonas JB, Degenring R, Kamppeter B, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment of diffuse diabetic macular edema. Am J Ophthalmol 2004; (in press). - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Ophthalmology 1991;98:807–2. - PubMed
    1. Jonas JB, Akkoyun I, Budde WM, et al. Intravitreal re-injection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 2004;122:218–22. - PubMed

MeSH terms

Substances